Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04453449 · ClinicalTrials.gov registry record
The Effect of Midazolam Sedation on Diagnostic Medial Branch Blocks
A clinical trial, sponsored by Henry Ford Health System.
- Completed
- Registry status
- 95
- Enrollment target
NCT04453449: Completed study, sponsored by Henry Ford Health System.
NCT04453449 is a clinical trial that has completed, run by Henry Ford Health System. The registered enrollment target is 95 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04453449 has completed, sponsored by Henry Ford Health System.
- COMPLETED
- Registry status
- 95 participants
- Enrollment target
Study Summary
This prospective observational study aims to investigate the effect of midazolam sedation on the diagnostic validity of diagnostic lumbar medial branch block in patients diagnosed with lumbar spondylosis without myelopathy.
Primary Outcome
The number of positive diagnostic lumbar medial branch blocks (defined by at least 80% pain relief) in patients who receive midazolam sedation during their diagnostic blocks will be compared to patients who do not receive sedation.
Interventions
- DRUG Midazolam
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 95 participants |
| Start Date | 2020-06-25 |
| Est. Completion | 2021-10-15 |
What the finished NCT04453449 record still lists
NCT04453449 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 95 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Midazolam is the first listed.
NCT04453449 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04453449 about?
NCT04453449 is a clinical study titled "The Effect of Midazolam Sedation on Diagnostic Medial Branch Blocks". This prospective observational study aims to investigate the effect of midazolam sedation on the diagnostic validity of diagnostic lumbar medial branch block in patients diagnosed with lumbar spondylosis without myelopathy.
What is the current status of trial NCT04453449?
This trial is currently completed. The enrollment target is 95 participants. The study started on 2020-06-25. Estimated completion is 2021-10-15.
What interventions are being tested in trial NCT04453449?
The interventions under investigation include: Midazolam (DRUG).
Who is sponsoring clinical trial NCT04453449?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03339128 · 95 participants · Phase 2
Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children
- NCT03509961 · 95 participants · Phase 2
The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL
- NCT03694756 · 95 participants · NA
TMEM-MRI: A Pilot Feasibility Study of MRI for Imaging of TMEM in Patients With Operable Breast Cancer
- NCT04206215 · 95 participants · NA
Noninvasive Brain Stimulation for Treating Carpal Tunnel Syndrome
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI